台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效

生華科

(6492)
可現股當沖
  • 股價
    41.35
  • 漲跌
    ▼0.25
  • 漲幅
    -0.60%
  • 成交量
    84
  • 產業
    上櫃 生技醫療類股
  • 147人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
生華科 (6492)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/05/08     後一日»

券商獲利排行 - 2024/05/08

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  1.68%3.53.5005541.741.34241.4
  1.08%3.203.2-70741.8041.841.4
  0.96%2.402.4-60641.8041.841.4
  1.55%202-3034204241.4
  1.43%1.801.8-3034204241.4
  1.39%1.801.8-30341.9041.941.4
  1.31%1.701.7-30341.9041.941.4
  0.87%1.40.41-31441.641.341.741.4
  0.96%0.800.8-10241.841.941.841.4
  0.90%0.80.8002241.841.64241.4
  0.60%0.700.7-30341.6041.641.4
  0.60%0.700.7-30341.6041.641.4
  0.52%0.700.7-30341.6041.641.4
  1.55%0.700.7-1014204241.4
  1.55%0.700.7-1014204241.4
  1.43%0.600.6-1014204241.4
  0.96%0.400.4-10141.8041.841.4
  0.48%0.400.4-20241.6041.641.4
  0.36%0.300.3-20241.5041.541.4
  0.72%0.300.3-10141.7041.741.4
  0.72%0.300.3-10141.7041.741.4
  0.62%0.30.3001141.741.641.941.4
  0.60%0.300.3-10141.6041.641.4
  0.60%0.300.300141.641.941.641.4
  0.57%0.200.2-10141.6041.641.4
  0.48%0.200.2-10141.6041.641.4
  0.48%0.200.2-10141.6041.641.4
  0.36%0.200.2-10141.5041.541.4
  0.36%0.10.1001141.541.541.641.4
  0.24%0.100.111041.341.3041.4
  0.12%00001142424241.4
  0.12%00011041.341.3041.4
  0.12%00011041.341.3041.4
  0.03%00044041.341.3041.4
   00000041.941.9041.4
   0000004242041.4
   00000041.241.2041.4
   00000041.8041.841.4
   00000041.241.2041.4
   00000041.2041.241.4
   00000041.941.9041.4
   00000041.9041.941.4
   00000041.941.941.941.4
   00000041.941.9041.4
   0000004204241.4
   00000041.2041.241.4
   0000004242041.4
   000000424241.941.4
  0.00%00011041.441.4041.4
  -0.02%000-50541.3041.341.4

券商虧損排行 - 2024/05/08

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -1.12%-4.70-4.71010041.841.8041.4
  -1.01%-4.70-4.71111041.841.8041.4
  -1.08%-3.20-3.277041.841.8041.4
  -1.31%-1.70-1.733041.941.9041.4
  -1.55%-1.30-1.32204242041.4
  -0.33%-1.30.3-1.679241.641.641.741.4
  -1.32%-1.1-1.1002241.541.841.341.4
  -0.48%-10-155041.641.6041.4
  -0.80%-10-133041.741.7041.4
  -0.80%-1-0.2-0.823141.741.841.641.4
  -0.31%-0.90-0.977041.541.5041.4
  -1.55%-0.70-0.71104242041.4
  -1.55%-0.70-0.71104242041.4
  -0.78%-0.7-0.7002241.84241.641.4
  -0.48%-0.60-0.633041.641.6041.4
  -1.35%-0.60-0.611041.941.9041.4
  -0.11%-0.50-0.5-1101141.3041.341.4
  -0.72%-0.30-0.311041.741.7041.4
  -0.72%-0.3-0.3001141.841.941.641.4
  -0.60%-0.30-0.311041.641.6041.4
  -0.60%-0.30-0.311041.641.6041.4
  -0.60%-0.30-0.311041.641.6041.4
  -0.12%-0.10-0.1-20241.3041.341.4
  -0.12%000-10141.3041.341.4
  -0.12%000-10141.3041.341.4
  -0.02%000-50541.3041.341.4
  0.00%00011041.441.4041.4
   00000041.941.9041.4
   0000004242041.4
   00000041.2041.241.4
   00000041.941.9041.4
   00000041.941.941.941.4
   0000004204241.4
   00000041.2041.241.4
   00000041.941.9041.4
   00000041.9041.941.4
   00000041.241.2041.4
   0000004242041.4
   00000041.241.2041.4
   000000424241.941.4
   00000041.8041.841.4
  0.03%00044041.341.3041.4
  0.12%00011041.341.3041.4
  0.12%00011041.341.3041.4
  0.12%00001142424241.4
  0.24%0.100.111041.341.3041.4
  0.36%0.10.1001141.541.541.641.4
  0.36%0.200.2-10141.5041.541.4
  0.48%0.200.2-10141.6041.641.4
  0.48%0.200.2-10141.6041.641.4
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-23天前
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科泛病毒感染肺炎新藥 向美申請二期臨床Anue鉅亨-2023/10/19
生華科 相關文章
生華科 相關影音